Alivus Lifesciences Bull Case Target Achieved
By Prime Research | Updated at: Apr 13, 2026 06:21 PM IST
Open Free Demat Account
In our pick of the week report dated Jan 25, 2026 on Alivus Lifesciences, we had recommended to buy in the band of Rs 882-899 and add on dips to Rs 799-808 band for base case target of Rs 981 and bull case target of Rs 1077 over the next 4 quarters.
Today, the stock touched high of Rs 1077.7, thereby hitting our bull case target of Rs 1077, yielding a return of 21%.
Disclaimer
At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
